Global Reports

Despite intense trade tensions and multiple layers of risks, Allianz Trade upgrades 36 country risk ratings for only 14 downgrades.

Pharma growth accelerates with aging populations, rising chronic diseases, biosimilar competition, and AI-driven drug discovery transforming the industry.

Global GDP growth remains strong... for now. It is expected to reach +2.9% in 2026 and +2.8% in 2027, following a robust +3% in 2025.

Allianz Research forecasts global business insolvencies to rise +6% in 2025, and +5% in 2026, reaching record highs. Explore the global insolvency outlook for 2026-27, including the risks from low growth, persistent financing cost and sector fragilities.

Explore our mid-year 2025-26 global economic outlook. With GDP growth expected at its slowest pace since 2008, rising trade tensions, fiscal risks, and divergent central bank policies shape a challenging future for both developed and emerging markets.

Explore key 2025 trends in the Asia-Pacific chemicals sector, from industrial growth and sustainability to diversified supply chains shaped by post-COVID and geopolitical shifts.

The semiconductor industry is recovering, with AI, 5G, and data centers driving demand. Explore key trends, electronics market risks, insolvency concerns, and global supply chain shifts. Get expert insights on the trillion-dollar chip market—download the full report now.

Explore the effects of US tariffs on global trade, including risks to China, Canada, Mexico, and emerging markets, amidst weaker export prices and currency fluctuations.

The second edition of our flagship country risk report provides an overview of the risks to businesses from the domestic and international environment in 2025.